参考文献:(上下滑动可浏览)1.FDA’s Decision to Approve New Treatment for Alzheimer’s Disease,https://www.fda.gov/drugs/news-events-human-drugs/fdas-decision-approve-new-treatment-alzheimers-disease
2. https://jamanetwork.com/journals/jama-health-forum/fullarticle/2788098
3. https://www.nytimes.com/2021/07/14/health/cleveland-clinic-aduhelm.html?campaign_id=60&emc=edit_na_20210715&instance_id=0&nl=breaking-news&ref=headline®i_id=145327320&segment_id=63531&user_id=ebac11ba9344b466151da49e9daca00f
4. https://www.nytimes.com/2021/09/02/health/aduhelm-fda.html
5. https://www.bmj.com/content/375/bmj.n3127.long
6.https://nordot.app/846353221462769664?c=445918389795193953
7.https://www.cms.gov/newsroom/press-releases/cms-finalizes-medicare-coverage-policy-monoclonal-antibodies-directed-against-amyloid-treatment
8. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2012.1073?journalCode=hlthaff
9.https://www.cms.gov/medicare-coverage-database/view/ncacal-public-comments.aspx?ncaId=305&fromTracking=Y&
10.https://www.philgutis.com/home
11.https://mp.weixin.qq.com/s/cXeL-EmXTZ2JjKru4cYWUA
12. https://www.science.org/content/blog-post/aduhelm-again
13.https://www.fiercepharma.com/pharma/after-aduhelm-controversy-congress-looks-strengthen-fdas-accelerated-approval-powers-wsj
14. https://www.nature.com/articles/s41573-022-00391-w
15.https://pubmed.ncbi.nlm.nih.gov/?sort=date&size=100&term=Breitner+JC&cauthor_id=26208958